COGT earnings: a negative outcome, -8.3%

On May 10, 2022, Cogent Biosciences, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.3% in the window around the event. It had already run -26.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.